ITGAX and squamous cell carcinoma: This resultis different from the observations we made in other disease models, includingpsoriasis and squamous cell carcinoma, where the CD11c+ CD1c+ DCpopulation stays relatively unchanged in number, but the CD11c+ CD1c−DC population shows a dramatic expansion [32].